|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/725 | (2006.01) |
| A61K 31/454 | (2013.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/7088 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K2319/03 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2319/70 | (2013.01) | ||
| A61K 31/7088 | (2006.01) | ||
| C07K 14/7051 | (2013.01) |
| (11) | Patento numeris | 3528851 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17862754.3 |
| Europos patento paraiškos padavimo data | 2017-10-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-04-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/057474 |
| Data | 2017-10-19 |
| (87) | Numeris | WO 2018/075820 |
| Data | 2018-04-26 |
| (30) | Numeris | Data | Šalis |
| 201662410822 P | 2016-10-20 | US |
| (72) |
XU, Shuichan , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | CEREBLON-BASED HETERODIMERIZABLE CHIMERIC ANTIGEN RECEPTORS |
| CEREBLON-BASED HETERODIMERIZABLE CHIMERIC ANTIGEN RECEPTORS |